AnaptysBio Inc (NASDAQ:ANAB) currently has a daily average trading volume of 735.74K but it saw 892748 shares traded in last market. With a market cap of 662.82M USD, the company’s current market price of $22.56 came rising about 7.94 while comparing to the previous closing price of $20.90. In past 52 weeks, the stock remained buoying in the range of price level as high as $41.31 and as low as $12.21.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Wolfe Research which initiated the stock as “Outperform” in its note to investors issued on February 04, 2025, recommending a price target of $25 for it. H.C. Wainwright downgraded its recommendation for the stock as a “Neutral” from “Buy” on December 11, 2024 while assigning a price target range of $52-$19.
Over the week, ANAB’s stock price is moving 8.44% up while it is 6.52% when we observe its performance for the past one month. Year-to-date it is 70.39% up and over the past year, the stock is showing a downside performance of -5.65%.
Currently, AnaptysBio Inc’s total number of outstanding shares is 30.39M with 5.06% of that held by the insiders while 134.18% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -37.20% and return on equity (ROE) at -343.83%. Stock’s beta reads -0.28. Stock has a price to book (P/B) ratio of 20.15 while price to sale or P/S ratio amounts to 5.92. Its return on asset (ROA) is -33.97% on average.
